Neuroblastoma
📧 Sign up to get email alerts when something new happens for Neuroblastoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2014-06-24Clinical Trial Update: Combination Chemotherapy With or Without Filgrastim Before Surgery, High-Dose Chemotherapy, and Radiation Therapy Followed by Isotretinoin With or Without Monoclonal Antibody in Treating Patients With Neuroblastoma [Phase 3]
Phase 3 clinical trial evaluating combination chemotherapy with or without filgrastim before surgery, followed by high-dose chemotherapy and…
-
CLINICAL_TRIALS trial_result · 2014-06-17Clinical Trial Update: Vorinostat With or Without Isotretinoin in Treating Young Patients With Recurrent or Refractory Solid Tumors, Lymphoma, or Leukemia [Phase 1]
Phase 1 study evaluating vorinostat with or without isotretinoin in pediatric patients with recurrent or refractory solid tumors, lymphoma, …
-
CLINICAL_TRIALS research · 2014-04-14Clinical Trial Update: Evaluation of 18F-dopa and 123I-MIBG Uptake in the Patients With Neuroblastoma
This clinical trial update examines uptake of two imaging radiotracers, 18F-dopa and 123I-MIBG, in patients with neuroblastoma to evaluate i…
-
CLINICAL_TRIALS trial_result · 2014-03-28Clinical Trial Update: Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Infants With Malignant Brain or Spinal Cord Tumors [Phase 1]
A Phase 1 clinical trial evaluates chemotherapy plus peripheral stem cell transplantation in infants with malignant brain or spinal cord tum…
-
CLINICAL_TRIALS trial_result · 2014-02-28Clinical Trial Update: ABT-751 in Treating Children With Neuroblastoma That Has Relapsed or Not Responded to Previous Treatment [Phase 2]
Phase 2 trial of ABT-751 in children with relapsed or refractory neuroblastoma has completed and results were posted in 2014.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2014-02-14Clinical Trial Update: Development of Strategies to Increase Enrollment in Clinical Trials for Children With Cancer
This clinical trial update describes strategies being developed to increase enrollment of pediatric cancer patients in clinical trials.
-
CLINICAL_TRIALS trial_result · 2014-02-13Clinical Trial Update: Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Neuroblastoma [Phase 2]
This document provides an update on a Phase 2 trial evaluating combination chemotherapy plus peripheral stem cell transplantation for childr…
-
CLINICAL_TRIALS trial_result · 2014-02-13Clinical Trial Update: Induction Chemotherapy Using Cyclophosphamide and Topotecan in Treating Patients Who Are Undergoing Autologous Peripheral Stem Cell Transplantation for Newly Diagnosed or Progressive Neuroblastoma [Phase 1]
This Phase 1 trial evaluated induction chemotherapy with cyclophosphamide and topotecan prior to autologous stem cell transplantation in pat…
-
CLINICAL_TRIALS trial_result · 2014-01-30Clinical Trial Update: Seneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine Features [Phase 1]
Phase 1 clinical trial update for Seneca Valley Virus-001 with Cyclophosphamide in pediatric patients with relapsed/refractory neuroblastoma…
-
CLINICAL_TRIALS trial_result · 2014-01-16Clinical Trial Update: hu14.18-Interleukin-2 Fusion Protein in Treating Young Patients With Recurrent or Refractory Neuroblastoma [Phase 2]
A Phase 2 trial of the hu14.18-Interleukin-2 fusion protein in young patients with recurrent or refractory neuroblastoma has completed enrol…
-
CLINICAL_TRIALS trial_result · 2014-01-16Clinical Trial Update: Irinotecan and Temozolomide in Treating Young Patients With Recurrent Neuroblastoma [Phase 2]
Phase 2 trial by the Children's Oncology Group evaluated irinotecan and temozolomide in young patients with recurrent neuroblastoma; results…
-
CLINICAL_TRIALS trial_result · 2014-01-10Clinical Trial Update: Umbilical Cord Blood for Stem Cell Transplantation in Treating Young Patients With Malignant or Nonmalignant Diseases [Phase 2]
Phase 2 clinical trial evaluating umbilical cord blood stem cell transplantation for treating malignant and nonmalignant diseases in young p…
-
CLINICAL_TRIALS trial_result · 2013-12-19Clinical Trial Update: Therapy Based on Stage of Disease and Risk Assessment in Treating Children With Neuroblastoma [Phase 3]
A Phase 3 trial evaluating stage-based, risk-adapted therapy for children with neuroblastoma has completed.
-
CLINICAL_TRIALS trial_result · 2013-12-19Clinical Trial Update: Combination Chemotherapy or Observation Following Surgery in Treating Infants With Neuroblastoma [Phase 2]
A Phase 2 trial comparing combination chemotherapy to observation after surgery in infants with Neuroblastoma has completed.
-
CLINICAL_TRIALS trial_result · 2013-12-18Clinical Trial Update: Vaccine Therapy and Interleukin-2 in Treating Young Patients With Relapsed or Refractory Ewing's Sarcoma or Neuroblastoma [Phase 1]
Phase 1 clinical trial evaluating a cancer vaccine therapy in combination with Interleukin-2 for relapsed or refractory Ewing sarcoma or Neu…
-
CLINICAL_TRIALS trial_result · 2013-12-16Clinical Trial Update: R(+)XK469 in Treating Patients With Advanced Neuroblastoma [Phase 1]
A Phase 1 trial of R(+)-XK469 in patients with advanced neuroblastoma has completed.
-
CLINICAL_TRIALS withdrawal · 2013-12-10Clinical Trial Update: Aflac ST1001 Prolonged Isotretinoin [Phase 1]
A Phase 1 trial of Aflac ST1001 Prolonged Isotretinoin for neuroblastoma has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2013-12-04Clinical Trial Update: Combination Chemotherapy Before Surgery in Treating Children With Localized Neuroblastoma [Phase 3]
This is an update on a Phase 3 clinical trial evaluating combination chemotherapy before surgery for localized neuroblastoma in children.
-
CLINICAL_TRIALS research · 2013-11-18Clinical Trial Update: A Pilot Study on ALK Gene Mutations in Neuroblastoma
This document reports a pilot clinical trial investigating ALK gene mutations in neuroblastoma. The status of the trial is unknown.
-
CLINICAL_TRIALS trial_result · 2013-10-31Clinical Trial Update: Monoclonal Antibody Therapy Plus Etoposide in Treating Patients With Neuroblastoma [Phase 2]
A Phase 2 clinical trial update evaluates the combination of monoclonal antibody therapy with etoposide for neuroblastoma.
-
CLINICAL_TRIALS trial_result · 2013-10-16Clinical Trial Update: Monoclonal Antibody 3F8 and GM-CSF in Treating Young Patients With High-Risk, Refractory or Relapsed Neuroblastoma [Phase 1]
Phase 1 clinical trial update evaluating the combination of the monoclonal antibody 3F8 and GM-CSF (sargramostim) in young patients with hig…
-
CLINICAL_TRIALS trial_result · 2013-10-08Clinical Trial Update: Fenretinide in Treating Children With Recurrent or Resistant Neuroblastoma [Phase 2]
A Phase 2 clinical trial evaluating fenretinide in children with recurrent or resistant neuroblastoma has completed.
-
CLINICAL_TRIALS trial_result · 2013-09-30Clinical Trial Update: Decitabine, Doxorubicin, and Cyclophosphamide in Treating Children With Relapsed or Refractory Solid Tumors or Neuroblastoma [Phase 1]
Phase 1 clinical trial evaluating a combination of decitabine, doxorubicin, and cyclophosphamide in children with relapsed or refractory sol…
-
CLINICAL_TRIALS research · 2013-09-20Clinical Trial Update: Combination Chemotherapy With or Without Radiation Therapy in Treating Children With Brain Tumors [Phase 2]
A Phase 2 clinical trial evaluating combination chemotherapy with or without radiation therapy for children with brain tumors.
-
CLINICAL_TRIALS trial_result · 2013-09-20Clinical Trial Update: Observation of Young Patients With Localized Neuroblastoma Who Have Undergone Surgery Only [Phase 2]
A Phase 2 observational trial updates outcomes for young patients with localized neuroblastoma who were treated with surgery only.